Prospects for new lung cancer treatments that target EMT signaling

研究成果: Review article査読

53 被引用数 (Scopus)

抄録

Lung cancer is the most common cancer worldwide. Treatment options for lung cancer include surgery, radiation therapy, chemotherapy, molecularly targeted therapy including epidermal growth factor receptor or anaplastic lymphoma kinase inhibitors, and immunotherapy. These treatments can be administered alone or in combination. Despite therapeutic advances, however, lung cancer remains the leading cause of cancer death. Recent studies have indicated that epithelial-mesenchymal transition (EMT) is associated with malignancy in various types of cancer, and activation of EMT signaling in cancer cells is widely considered to contribute to metastasis, recurrence, or therapeutic resistance. In this review, we provide an overview of the role of EMT in the progression of lung cancer. We also discuss the prospects for new therapeutic strategies that target EMT signaling in lung cancer. Developmental Dynamics 247:462–472, 2018.

本文言語English
ページ(範囲)462-472
ページ数11
ジャーナルDevelopmental Dynamics
247
3
DOI
出版ステータスPublished - 2018 3

ASJC Scopus subject areas

  • 発生生物学

フィンガープリント

「Prospects for new lung cancer treatments that target EMT signaling」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル